Bank of New York Mellon’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-209,222
Closed -$136K 4239
2025
Q1
$136K Sell
209,222
-8,405
-4% -$5.47K ﹤0.01% 3943
2024
Q4
$400K Buy
217,627
+2,578
+1% +$4.74K ﹤0.01% 3611
2024
Q3
$744K Sell
215,049
-57,670
-21% -$200K ﹤0.01% 3291
2024
Q2
$799K Buy
272,719
+88,034
+48% +$258K ﹤0.01% 3315
2024
Q1
$1.04M Sell
184,685
-77,939
-30% -$440K ﹤0.01% 3123
2023
Q4
$1.13M Buy
262,624
+1,173
+0.4% +$5.03K ﹤0.01% 3125
2023
Q3
$907K Buy
261,451
+8,633
+3% +$30K ﹤0.01% 3207
2023
Q2
$1.18M Buy
252,818
+12,574
+5% +$58.5K ﹤0.01% 3105
2023
Q1
$1.11M Buy
240,244
+1,539
+0.6% +$7.11K ﹤0.01% 3089
2022
Q4
$1.93M Buy
238,705
+82,832
+53% +$669K ﹤0.01% 2871
2022
Q3
$865K Buy
155,873
+18,890
+14% +$105K ﹤0.01% 3277
2022
Q2
$714K Sell
136,983
-13,635
-9% -$71.1K ﹤0.01% 3372
2022
Q1
$1.24M Buy
150,618
+1,003
+0.7% +$8.24K ﹤0.01% 3178
2021
Q4
$2.23M Sell
149,615
-17,264
-10% -$257K ﹤0.01% 2930
2021
Q3
$3.15M Buy
166,879
+13,283
+9% +$251K ﹤0.01% 2737
2021
Q2
$2.86M Buy
153,596
+52,198
+51% +$971K ﹤0.01% 2777
2021
Q1
$2.31M Buy
101,398
+583
+0.6% +$13.3K ﹤0.01% 2842
2020
Q4
$2.19M Buy
100,815
+39,452
+64% +$857K ﹤0.01% 2794
2020
Q3
$617K Buy
61,363
+11,458
+23% +$115K ﹤0.01% 3383
2020
Q2
$387K Buy
49,905
+21,051
+73% +$163K ﹤0.01% 3594
2020
Q1
$295K Buy
28,854
+16
+0.1% +$164 ﹤0.01% 3604
2019
Q4
$317K Hold
28,838
﹤0.01% 3780
2019
Q3
$262K Sell
28,838
-1,634
-5% -$14.8K ﹤0.01% 3818
2019
Q2
$347K Buy
30,472
+15,591
+105% +$178K ﹤0.01% 3751
2019
Q1
$169K Buy
+14,881
New +$169K ﹤0.01% 3910